I graduated from the University of Buenos Aires with a Bachelor's degree in Biological Sciences (2001) and earned a PhD in Biological Chemistry from the same university (2007). I am currently a researcher at INTA and CONICET, working in the Pox and Adenovirus-Vectorized Vaccines group at the Biotechnology Institute IABiMO UEDD INTA-CONICET. I have extensive experience in cell culture management, classical virology techniques, molecular biology techniques, vaccine design and production (both conventional and recombinant), diagnostic methods and immune response evaluation. In our laboratory, we work on the production and evaluation of recombinant poxviruses (MVA and CNPV) and replication-deficient human adenovirus type 5 as rationally designed vaccine vectors using various antigens as models (OVA, antigen 85A from M. bovis, rabies virus glycoprotein, BoHV-1 glycoprotein D). In this group, I implemented methodologies for the generation of double recombinant MVA viruses for use as vaccine vectors. Throughout my career, I have been involved in the development, characterization, and transfer to companies of biotechnological immunogens such as a marker vaccine against bovine herpesvirus 1 (BoHV-1∆Eβgal), a non-replicative viral vectored vaccine against IBDV for poultry (R-VAC INMUNER IBD), and the patent “Chimeric polypeptide, vaccine against babesiosis, immunization methods, detection methods, and kit.”
INTA
Buenos Aires, Argentina
Biotechnology Institute
CONICET
Buenos Aires, Argentina